• Reports

      Reports

      Stay ahead and make informed decisions with Delvens insightful analysis on key business and technological trends.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Best Practice Guide

      Best Practice Guides

      The Delvens Best Practice Team offers practical tactics, procedures, and resources to help you address the major growth-related dos and don'ts.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Expertise

      Expertise

      Delvens' decades of experience helps you to strategize, plan, optimize and win.

      See What we can do
      • Syndicated Research
      • Custom Research
      • Consulting
      • Implementation Support
      • Audio-Video Infographic Workshops
      • Subscription Model
      • Bundle Reports Model
      • Best Practice Guides
  • Innovation

      Innovation

      Gain thought-provoking insights on some of the biggest trends in the world to guide you in the phase of innovation.

      Let's Innovate

      Latest Chronicles

      Pharma Businesses

      Pharma businesses that are rewired will win in the digital era

      13th July 2023

      Featured Chronicle

      ESG

      Why ESG is more important than ever!

      4th November 2022
  • Innovation
  • Explore

      Explore

      From accelerating growth and providing strategic vision to the world's biggest brands, to lunch-break sneaker shopping on Melrose, and thirsty Thursdays at the local pubs. We have a Hustling atmosphere because growing together should be fun, or why do it?

      Let's Explore Something

      About

      • Who We Are
      • Why Choose Us
      • Research Methodology
      • Careers
      • Contact

      Help

      • Customer FAQs
      • How To Order
      • Delivery Method
      • Return Policy
      • Privacy Policy
      • Terms of Use
  • Newscast

      Blogs

      The Pros and Cons of Cloud Computing

      The Pros and Cons of Cloud Computing

      13th July 2023
      Let's Read

      Press Room

      Healthcare AI Innovation

      Healthcare AI innovation: a new era of patientcare

      13th July 2023
      Let's Understand

      Article

      Electric Vehicle Thermal Management System (EVTMS) Market

      19th May 2023
      Let's Study
  • Newscast
      • Blog
      • Article
      • Pressroom
Food & Beverages Icon

Human Milk Oligosaccharides (HMO) Market – Trends Forecast Till 2030

Human Milk Oligosaccharides (HMO) Market by Type (2’ Fl, 3’ Fl, 3’ Sl, 6’ Sl), Application (Infant Formula, Functional Food & Beverages, Food Supplement), Concentration (Acidic, Neutral), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

  • Published Date : May 2023
  • Base Year Estimate : 2022
  • Report ID : D-FB-HMOM-1350
  • Format :
  • Number of Pages : 540
  • Domain : Food & Beverages
  1. Food & Beverages
  2. Human Milk Oligosaccharides (HMO) Market – Trends Forecast Till 2030
Buy Now Get Free Sample Now
REPORT SYNOPSIS
Market Snapshot Market Overview Delvens Industry Expert's Standpoint Market Portfolio Key Findings Regional Analysis Competitive Landscape Recent Developments Reasons to Acquire Report Scope
Table Of Content Frequently Asked Questions

Market Snapshot

Market Overview

The global Human Milk Oligosaccharides (HMO) Market size is projected to reach a CAGR of 23.4% from 2023-2030.

Human milk oligosaccharides, also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations exclusively in human breast milk. Human milk oligosaccharides promote the development of the immune system, can reduce pathogen infections, and improve brain development and cognition. Approximately 200 structurally different human milk oligosaccharides are known and the exact composting of these varies from mother to mother.

The functional benefits of these products have created a huge demand for the biosynthetic production of HMOs for use as additives in infant formulas and other dietary products. HMO molecules can be produced chemically, through fermentation, or through enzymatic synthesis. Moreover, the surge in demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements. One of the major factors and Human Milk Oligosaccharides (HMO) market trends that boosts the Human Milk Oligosaccharides (HMO) market growth is the availability of new technologies such as enzymatic trans-glycosylation, which is used for artificially synthesizing the HMOs. Other major factors driving the demand for HMOs around the world include improvement in lifestyle and rise in concerns about health & wellness. Furthermore, HMOs in food supplements and functional food and beverage products can aid in the treatment of specific disorders and high-risk health conditions, which is acts as a key driving force of the global Human Milk Oligosaccharides (HMO) market. This has created Human Milk Oligosaccharides (HMO) market opportunity. However, high costs associated with the product is expected to pose a challenge for the growth of the market during Human Milk Oligosaccharides (HMO) market forecast.

On the other hand, the absence of technologies for large-scale manufacturing, the massive price of research and development, and the rigorous federal regulations are all expected to limit the expansion of the HMO industry. Additionally, it is possible that the high prices connected with the goods would hinder market expansion throughout the projection period.

The COVID-19 pandemic had a significant impact on the Human Milk Oligosaccharides (HMO) market. The demand for HMO increased during the lockdown due to panic buying for at-home consumption during the initial phase of the pandemic. As a result, the sales of HMOs escalated during the pandemic, due to the fact that it serves as an immunity booster.

Delvens Industry Expert's Standpoint

The demand for infant formula-containing HMOs and increased awareness of the health advantages of HMOs are driving the growth and dynamism of the human milk oligosaccharides (HMO) market. While there are now many competitors operating in the industry, it is fragmented, and there are some consolidations as larger businesses want to increase their offers and acquire a competitive edge. Regulatory oversight of the market is also present, notably in relation to the efficacy and safety of HMOs used in baby formula. Overall, it is anticipated that the HMO market will expand over the upcoming years as a result of growing demand from emerging nations and ongoing studies into the health advantages of HMOs.

Market Portfolio

Key Findings

  • The type segment is further segmented into 2’ FL, 3’ FL, 3’ SL, and 6’ SL. The 2’FL segment garnered the highest market share in 2022, as 2'-fucosyllactose (2’FL) is well-known for its ability to protect against infectious diseases by preventing toxins and pathogens from adhering to epithelial cells. On the basis of application, the infant formula segment is anticipated to dominate the Human Milk Oligosaccharides (HMO) market share during the forecast period. This is attributed to beneficial properties offered by HMOs such as brain development and memory enhancement in infants.
     
  • Human milk oligosaccharides, also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations exclusively in human breast milk.
     
  • Asia Pacific consisting of countries like China, India, Japan, Australia & New Zealand, and Others is found to dominate the HMO market with the presence of a large consumer base for HMO derivative products.
     
  • The COVID-19 pandemic had a significant impact on the Human Milk Oligosaccharides (HMO) market.

Regional Analysis

Asia Pacific to Dominate the Market

  • Asia Pacific consisting of countries like China, India, Japan, Australia & New Zealand, and Others is found to dominate the HMO market with the presence of a large consumer base for HMO derivative products.
     
  • The region is densely populated with countries like China and India, witnessing a rapid rise in infant population every year. This tendency of the population rising is influencing the infant formula market where HMO is used as a vital ingredient for formulating infant foods and other supplements.

Competitive Landscape

  • Abbott Laboratories
  • BASF S.E.
  • Biosynth Carbosynth
  • Chr. Hansen Holding A/S
  • Dextra Laboratories Ltd.
  • Dupont Nutrition & Biosciences
  • Elicityl S.A.
  • Glycom A/S
  • Glycosyn
  • Inbiose NV
  • Medolac Laboratories
  • Neolacta Lifesciences Pvt. Ltd
  • Nestle Health Science
  • Royal DSM
  • ZuChem